Maintenence rituximab following induction in autoimmune cytopenias
British Journal of Haematology · 2023
DOI: 10.1111/bjh.18814 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Manoj P Rai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Oregon Health and Science University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
About 50% of immune thrombocytopenia (ITP) patients respond to rituximab induction, but most relapse. The effectiveness of rituximab maintenance remains untested. This study included autoimmune cytopenia patients who had previously responded to rituximab induction but subsequently relapsed. After re‐induction, patients received rituximab maintenance regimen consisting of a single 375 mg/m 2 dose administered at 4 month intervals, with a maximum of 6 doses. Primary endpoints were duration of response and safety. Sixteen patients: ITP (9), autoimmune haemolytic anaemia (2), and Evans syndrome (5) received rituximab maintenance. 15/16 achieved complete response (CR); 8/15 CR + 1 partial reponse remain in remission. Median response: 43 months; estimated 5‐year relapse‐free >50%. Three developed hypogammaglobulinemia. Rituximab maintenance led to prolonged remissions in patients with autoimmune cytopenias who had previously responded to rituximab induction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Oregon Health and Science University, Portland, Oregon, USA.
- Divisions of Hematology/Oncology and Pediatric Hematology-Oncology, Weill Cornell Medical College, New York, New York, USA.
ORCID-Profile: Manoj P Rai, Eun-Ju Lee, James B Bussel
Zitieren
APA
Rai, M. P., Lee, E. J., & Bussel, J. B. (2023). Maintenence rituximab following induction in autoimmune cytopenias. British Journal of Haematology. https://doi.org/10.1111/bjh.18814
Vancouver
Rai MP, Lee EJ, Bussel JB. Maintenence rituximab following induction in autoimmune cytopenias. British Journal of Haematology. 2023. doi:10.1111/bjh.18814
BibTeX
@article{Rai2023,
author = {Rai, Manoj P and Lee, Eun-Ju and Bussel, James B},
title = {Maintenence rituximab following induction in autoimmune cytopenias},
journal = {British Journal of Haematology},
year = {2023},
doi = {10.1111/bjh.18814}
}
EUVIMED